Genus plc
File:Genus logo.png | |
Company type | Public |
---|---|
LSE: GNS | |
ISIN | GB0002074580 ![]() |
Industry | Biotechnology |
Founded | 1933 |
Headquarters | Basingstoke, Hampshire, UK |
Key people | Bob Lawson, Chairman[1] Karim Bitar, CEO[1] |
Revenue | £459.1 million (2017)[2] |
£38.2 million (2017)[2] | |
£34.3 million (2017)[2] | |
Website | www |
Genus plc is a British-based business selling products manufactured using biotechnology to cattle and pig farmers. It is headquartered in Basingstoke and is a constituent of the FTSE 250 Index.
History
The business has its origins in the former Breeding & Production Division of the Milk Marketing Board which was established in 1933 and broken up in 1994.[3] In 1999 Genus acquired ABS Global, a company founded by J.R. Prentice in the US as the American Breeders Service in 1941 selling the semen of cattle.[4] In 2005 Genus acquired, through the takeover of Sygen International plc, PIC, a company founded by six pork producers in the UK as the Pig Improvement Company in 1962.[5]
Operations
The Company has two divisions:[6]
Board of directors
The board of directors is as follows:[1]
- Bob Lawson (Chairman)
- Karim Bitar (CEO)
- Stephen Wilson (Group Finance Director)
- Nigel Turner (Senior Non-Executive Director)
- Lysanne Gray (Non-Executive Director)
- Professor Duncan Maskell (Non-Executive Director)
- Lykele van der Broek (Non-Executive Director)
- Dan Hartley (Group General Counsel & Company Secretary)
References
- ^ a b c "Genus plc - Investor Relations - Genus Board". genusplc.com. Retrieved 28 March 2015.
- ^ a b c "Annual Report 2017" (PDF). Genus plc. Retrieved 25 March 2018.
- ^ The BSE Inquiry Archived 2008-10-10 at the Wayback Machine
- ^ ABS Global Parent Reports Positive Year-End Results and Stock Listing
- ^ "Genus Completes Acquisition Of Sygen". The Pig Site. Retrieved 28 March 2015.
- ^ "Genus". Market Watch. Retrieved 25 March 2018.